Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Slaoui

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Infectious Diseases|June 1, 1995
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccineD M Gordon, T W McGovern, U Krzych, et al.
The Journal of Infectious Diseases|August 1, 1997
Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in miceT L Keadle, K A Laycock, J K Miller, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis CT Fontanges, F Bailly, E Trepo, et al.
The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.
The Journal of Infectious Diseases|November 7, 1998
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccineJ A Stoute, K E Kester, U Krzych, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Infectious Diseases|June 1, 1995
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccineD M Gordon, T W McGovern, U Krzych, et al.
The Journal of Infectious Diseases|August 1, 1997
Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in miceT L Keadle, K A Laycock, J K Miller, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis CT Fontanges, F Bailly, E Trepo, et al.
The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.
The Journal of Infectious Diseases|November 7, 1998
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccineJ A Stoute, K E Kester, U Krzych, et al.
Pageof 6